Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BMO Capital reduced its price target on Moody's Corporation to $480 from $561 while keeping a Market Perform rating. The firm raised its financial estimates after Moody's reported stronger-than-expected results, but trimmed the target due to multiple compression in the sector. Management provided 2026 growth guidance and flagged AI-related opportun…
DA Davidson reduced its price target for Carvana Co. to $320 from $470 while retaining a Neutral rating, citing concerns that current valuation levels leave the stock vulnerable to even modest earnings misses. Carvana reported strong unit growth and revenue expansion but posted a slight profit miss, and other brokers maintain a range of more optimi…
BMO Capital Markets increased its price objective for eBay Inc. to $120 from $107 and kept an Outperform rating following quarterly results that beat consensus and guidance that topped expectations. The broker pointed to category acceleration, bullion and collectibles demand, and the Depop acquisition as drivers for upgraded forecasts. Multiple oth…
NRG (NRG) combines newly acquired flexible generation, a virtual power plant capability, and stronger FY26 guidance to offer an actionable long trade into the AI-driven electricity demand cycle. Valuation is reasonable on an EV/EBITDA of ~12 and FCF guidance that now targets $2.8-$3.3 billion for FY26; technicals show bullish momentum. This trade t…
Federal Reserve Bank of Minneapolis President Neel Kashkari criticized the practical value of cryptocurrency and questioned the utility of stablecoins compared with existing payment apps during a speaking engagement in North Dakota on Thursday. He also defended the Fed’s institutional independence in the face of political attacks, citing recent cri…
TD Cowen reaffirmed a Buy rating on Check Point Software (CHKP) and set a $260 price target, implying roughly 59% upside from current levels. The broker expects revenue growth to accelerate through fiscal 2026, points to healthy billings momentum in fiscal 2025, and views the stock's fiscal 2027 valuation as appealing despite a recent quarter that …
TD Cowen increased its price target on Clean Harbors (CLH) to $320 from $275 while keeping a Buy rating, citing a lower discount rate in its DCF model and modest upward revisions to 2026-2030 EBITDA. The firm highlighted a restarted M&A pipeline as a potential source of additional upside later in 2026. Recent quarterly results prompted other broker…
TD Cowen raised its price target on SolarEdge Technologies (SEDG) to $43 from $38 while keeping a Buy rating, citing fourth-quarter 2025 margin gains and positive free cash flow. The firm highlighted exports, Nexis and a single-SKU approach as drivers of margin expansion and market share growth, and pointed to a potential solid-state transformer ra…
TD Cowen raised its price target on Analog Devices to $400 from $355 while keeping a Buy rating, pointing to strength in datacenter-related businesses and aerospace and defense, and an improved gross margin of 62.84%. The stock trades at $343.54, near its 52-week high, and analysts broadly adjusted targets following robust results, though some segm…
Figure Technology Solutions (NASDAQ:FIGR) has launched FGRD, the first SEC-registered public equity to be issued and settled directly on blockchain infrastructure. The shares are available on the On-chain Public Equity Network (OPEN) and can be traded, lent, or borrowed through the Figure Markets app with T+0 settlement and real-time verification o…
A U.S.-backed Palestinian body charged with taking over Gaza's civil administration has launched applications for a new police force, setting eligibility rules for residents aged 18-35. The move comes ahead of an inaugural Board of Peace meeting in Washington where a multi-billion-dollar reconstruction plan and details of a U.N.-authorized stabiliz…
TD Cowen reiterated a Buy rating on Amgen with a $420 price target, emphasizing the promise of dazodalibep for both symptomatic and systemic Sjogren’s disease following positive Phase 2 ALISS results. The firm sees a sizable commercial opportunity in moderate-to-severe Sjogren’s and highlights upcoming Phase 3 readouts in 2026-2027, while other ana…
Truist Securities raised its price target on eBay to $94 from $92 following the company’s fourth-quarter 2025 results and first-quarter 2026 guidance. The firm maintained a Hold rating, citing sustained gross merchandise volume (GMV) growth, free cash flow protection and capital returns. eBay’s acquisition of Depop and outperformance in focus categ…
TD Cowen reduced its price target for Booking Holdings to $6,000 from $6,850 while keeping a Buy rating, citing investor sentiment around the company’s planned artificial intelligence investments. Booking reported stronger-than-expected fourth-quarter results with adjusted EPS of $48.80 and revenue of $6.35 billion; the company plans to accelerate …
Household expectations for inflation over the next year declined to 13.1% in February from 13.7% in January, central bank data show. Analysts say the drop, following a VAT-driven price spike at the start of the year, increases scope for additional monetary easing after the central bank trimmed its key rate by 50 basis points to 15.5%. Community dou…
RBC Capital cut its price objective on Wingstop Inc. (WING) to $340 from $350 while keeping an Outperform rating, pointing to weaker-than-expected first-quarter trends and heightened execution risk for initiatives such as Smart Kitchen and loyalty programs. The chain reported mixed fourth-quarter metrics, with EBITDA beating estimates and same-stor…
Truist Securities increased its price objective for Analog Devices to $364 from $291 while retaining a Hold recommendation. The firm pointed to cyclical strength driving stronger quarterly results and an improved outlook, raising its calendar year 2027 EPS estimate. Other brokerages have also raised targets and ratings following robust results and …
Maxim Group began coverage of Evaxion Biotech (EVAX) with a Buy rating and a $10 price target, highlighting the company's long-developed AI platform, a Merck strategic stake, and encouraging clinical results in melanoma. The target implies a potential 201% upside from the stock's current price of $3.32. Recent corporate developments include selecti…
Truist Securities raised its DoorDash price target to $340 from $330 and kept a Buy rating after the company reported fourth-quarter 2025 results roughly matching forecasts. Guidance for first-quarter 2026 points to higher gross order value but lower adjusted EBITDA at the midpoint, with management citing investments, weather and seasonal Dasher co…
Truist Securities reaffirmed a Buy rating on Praxis Precision Medicines (PRAX) and held a $500 price target, citing potential material upside from higher-than-expected pricing for ulixa in essential tremor. The firm’s base wholesale acquisition cost model is roughly $27,000 per year, but key opinion leaders signaled comfort with materially higher n…
D. Boral Capital downgraded GeoVax Labs Inc. (NASDAQ: GOVX) to Hold from Buy on Wednesday, pointing to constrained near-term visibility driven by limited catalysts and tight capital. The stock has tumbled sharply over the past year and saw an acute drop in the past week. The research note removed the firm's price target, highlighted a recent $1 mil…
UBS says a pronounced derating across global software valuations has opened selective buying opportunities, identifying five names that meet its valuation and earnings-revision criteria. The bank warns that macro and currency dynamics differ across regions and urges investors to favor U.S. software exposures over European peers.
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) saw its shares fall about 8% on Thursday following the announcement of a priced public offering expected to raise roughly $55 million in gross proceeds. The clinical-stage company is issuing common shares and pre-funded warrants, and has granted underwriters an option to purchase additional shares. Procee…
Moleculin Biotech Inc. (NASDAQ: MBRX) saw its stock fall 34.3% in premarket trading after announcing an agreement with certain warrant holders to immediately exercise outstanding warrants. The deal will bring in roughly $8.3 million in gross proceeds at $3.90 per share while creating new unregistered warrants that could lead to further dilution pen…
RBC Capital reduced its 12-month price target on Carvana Co. (CVNA) to $440 from $500 while keeping an Outperform rating, citing a fourth-quarter shortfall in gross profit per unit driven by the company returning more economics to buyers to push volume. Despite that miss and a step back in some reconditioning efficiency, Carvana is trading near its…
